‌

US Patent 11840572 Therapeutic antibodies and their uses

Patent 11840572 was granted and assigned to Pfizer on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

1

Patent attributes

Patent Applicant

1

Current Assignee

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Lei Wu1

Andrea Therese Hooper1

Malgorzata Agnieszka Nocula-Lugowska1

James Reasoner Apgar1

Date of Patent

December 12, 2023

1

Patent Application Number

173783771

Date Filed

July 16, 2021

1

Patent Citations

US Patent 9969809 Therapeutic antibodies and their uses

1

US Patent 11434292 Antibodies specific for CD3 and uses thereof

1

Patent Primary Examiner

1

Patent abstract

The present invention relates to antibodies that specifically bind to B7-H4 (B7 Homology 4, encoded by gene VTCN1) and bispecific antibodies that specifically bind to both B7-H4 and CD3 (Cluster of Differentiation 3), and polynucleotides, pharmaceutical compositions and methods and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11840572 Therapeutic antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.